litlas
Log inCreate account

Brett Leav

Active 2000–2025

39
Papers
18,902
Citations
28
h-index
37
i10-index

Citations

Citations per year for Brett Leav1969: 1 citations1974: 1 citations2002: 1 citations2003: 6 citations2004: 4 citations2005: 7 citations2006: 9 citations2007: 9 citations2008: 9 citations2009: 8 citations2010: 18 citations2011: 27 citations2012: 34 citations2013: 22 citations2014: 26 citations2015: 22 citations2016: 23 citations2017: 25 citations2018: 12 citations2019: 40 citations2020: 102 citations2021: 2,867 citations2022: 2,258 citations2023: 815 citations2024: 924 citations2025: 458 citations2026: 10 citations1970–1973: no citations, so these years are not shown1975–2001: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,858 citing papers, 26.5% of this breakdownChina: 816 citing papers, 7.6% of this breakdownUnited Kingdom: 716 citing papers, 6.7% of this breakdownItaly: 481 citing papers, 4.5% of this breakdownGermany: 464 citing papers, 4.3% of this breakdownCanada: 421 citing papers, 3.9% of this breakdownFrance: 274 citing papers, 2.6% of this breakdownAustralia: 273 citing papers, 2.5% of this breakdownSpain: 251 citing papers, 2.3% of this breakdownJapan: 250 citing papers, 2.3% of this breakdownNetherlands: 250 citing papers, 2.3% of this breakdownIndia: 228 citing papers, 2.1% of this breakdown
0%26.5%Other 32.4%

Institutions

Fields

  • Medicine72.2%
  • Biochemistry, Genetics and Molecular Biology14.8%
  • Immunology and Microbiology5%
  • Social Sciences3.1%
  • Mathematics1.5%
  • Materials Science0.5%
  • Other2.9%

Topics

  • SARS-CoV-2 and COVID-19 Research22.1%
  • COVID-19 Clinical Research Studies8.9%
  • Vaccine Coverage and Hesitancy5.5%
  • RNA Interference and Gene Delivery4.8%
  • Animal Virus Infections Studies3.6%
  • Immunotherapy and Immune Responses3.4%
  • Other51.7%

Coauthors

All papers

Open in search
  1. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

    Authors: Lindsey R. Baden, Hana M. El Sahly, Brandon Essink, Karen Kotloff, Sharon Frey, Rick Novak, David Diemert, Stephen A. Spector, Nadine Rouphael, C. Buddy Creech, John McGettigan, Shishir Khetan, Nathan Segall, Joel Solis, Adam Brosz, Carlos Fierro, Howard Schwartz, Kathleen Neuzil, Lawrence Corey, Peter Gilbert, Holly Janes, Dean Follmann, Mary Marovich, John Mascola, Laura Polakowski, Julie Ledgerwood, Barney S. Graham, Hamilton Bennett, Rolando Pajon, Conor Knightly, Brett Leav, Weiping Deng, Honghong Zhou, Shu Han, Melanie Ivarsson, Jacqueline Miller, Tal Zaks - New England Journal of Medicine 2020 cited by 10,720

  2. Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults

    Authors: Evan J. Anderson, Nadine Rouphael, Alicia T. Widge, Lisa A. Jackson, Paul C. Roberts, Mamodikoe Makhene, James D. Chappell, Mark R. Denison, Laura J. Stevens, Andrea J. Pruijssers, Adrian B. McDermott, Britta Flach, Bob C. Lin, Nicole A. Doria‐Rose, Sijy O’Dell, Stephen D. Schmidt, Kizzmekia S. Corbett, Phillip A. Swanson, Marcelino Padilla, Kathy M. Neuzil, Hamilton Bennett, Brett Leav, Mat Makowski, Jim Albert, Kaitlyn Cross, Venkata Viswanadh Edara, Katharine Floyd, Mehul S. Suthar, David Martínez, Ralph S. Baric, Wendy Buchanan, Catherine J. Luke, Varun K. Phadke, Christina A. Rostad, Julie E. Ledgerwood, Barney S. Graham, John H. Beigel - New England Journal of Medicine 2020 cited by 1,630

  3. Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase

    Authors: Hana M. El Sahly, Lindsey R. Baden, Brandon Essink, Susanne Doblecki‐Lewis, Judith M. Martin, Evan J. Anderson, Thomas Campbell, Jesse L. Clark, Lisa A. Jackson, Carl J. Fichtenbaum, Marcus Zervos, Bruce Rankin, Frank Eder, Gregory Feldman, C Kennelly, Laurie J. Han-Conrad, Michael Levin, Kathleen M. Neuzil, Lawrence Corey, Peter B. Gilbert, Holly Janes, Dean Follmann, Mary Marovich, Laura Polakowski, John R. Mascola, Julie E. Ledgerwood, Barney S. Graham, Allison August, Heather Clouting, Weiping Deng, Shu Han, Brett Leav, Deb Manzo, Rolando Pajón, F. Schödel, Joanne E. Tomassini, Honghong Zhou, Jacqueline M. Miller - New England Journal of Medicine 2021 cited by 658

  4. The safety and immunogenicity of two Zika virus mRNA vaccine candidates in healthy flavivirus baseline seropositive and seronegative adults: the results of two randomised, placebo-controlled, dose-ranging, phase 1 clinical trials

    Authors: Brandon Essink, Laurence Chu, William Seger, Elizabeth Barranco, Nancy Le Cam, Hamilton Bennett, Veronica Faughnan, Rolando Pajón, Yamuna Devi Paila, Brooke Bollman, Steven Wang, Jacqueline Dooley, Shiva Kalidindi, Brett Leav - The Lancet Infectious Diseases 2023 cited by 141

  5. Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants

    Authors: Amarendra Pegu, Sarah O’Connell, Stephen D. Schmidt, Sijy O’Dell, Chloe Adrienna Talana, Lilin Lai, Jim Albert, Evan J. Anderson, Hamilton Bennett, Kizzmekia S. Corbett, Britta Flach, Lisa A. Jackson, Brett Leav, Julie E. Ledgerwood, Catherine J. Luke, Mat Makowski, Martha Nason, Paul C. Roberts, Mario Roederer, Paulina A. Rebolledo, Christina A. Rostad, Nadine Rouphael, Wei Shi, Lingshu Wang, Alicia T. Widge, Eun Sung Yang, The mRNA-1273 Study Group§, John H. Beigel, Barney S. Graham, John R. Mascola, Mehul S. Suthar, Adrian B. McDermott, Nicole A. Doria‐Rose, Jae Arega, John H. Beigel, Wendy Buchanan, Mohammed Elsafy, Binh Hoang, Rebecca Lampley, Aparna Kolhekar, Hyung Il Koo, Catherine J. Luke, Mamodikoe Makhene, Seema Nayak, Rhonda Pikaart-Tautges, Paul C. Roberts, Janie Russell, Elisa Sindall, Jim Albert, Pratap Kunwar, Mat Makowski, Evan J. Anderson, Amer Bechnak, Mary Bower, Andrés Camacho-González, Matthew H. Collins, Ana Drobeniuc, Venkata Viswanadh Edara, Srilatha Edupuganti, Katharine Floyd, Theda Gibson, Cassie M. Grimsley Ackerley, Brandi Johnson, Satoshi Kamidani, Carol Kao, Colleen F. Kelley, Lilin Lai, Hollie Macenczak, Michele Paine McCullough, Etza Peters, Varun K. Phadke, Paulina A. Rebolledo, Christina A. Rostad, Nadine Rouphael, Erin M. Scherer, Amy C Sherman, Kathy Stephens, Mehul S. Suthar, Mehgan Teherani, Jessica Traenkner, Juton R. Winston, İnci Yıldırım, Lee Barr, Joyce Benoit, Barbara Carste, Joe Choe, Maya Dunstan, Roxanne Erolin, Jana ffitch, Colin Fields, Lisa A. Jackson, Erika Kiniry, Susan Lasicka, Stella E. Lee, M. Nguyen, Stephanie Pimienta, Janice Suyehira, Michael M. Witte, Hamilton Bennett, Nedim Emil Altaras and 58 more - Science 2021 cited by 602

  6. Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis

    Authors: Angela Choi, Matthew Koch, Kaichun Wu, Laurence Chu, LingZhi Ma, A V Hill, Naveen Nunna, Wenmei Huang, Judy Oestreicher, Tonya M. Colpitts, Hamilton Bennett, Holly Legault, Yamuna Devi Paila, Biliana Nestorova, Baoyu Ding, David C. Montefiori, Rolando Pajón, Jacqueline M. Miller, Brett Leav, Andrea Carfı́, Roderick McPhee, Darin K. Edwards - Nature Medicine 2021 cited by 449

  7. Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents

    Authors: Kashif Ali, Gary Berman, Honghong Zhou, Weiping Deng, Veronica Faughnan, Maria Coronado-Voges, Baoyu Ding, Jacqueline Dooley, Bethany Girard, William Hillebrand, Rolando Pajon, Jacqueline M. Miller, Brett Leav, Roderick McPhee - New England Journal of Medicine 2021 cited by 371

  8. Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19

    Authors: Nicole A. Doria‐Rose, Mehul S. Suthar, Mat Makowski, Sarah O’Connell, Adrian B. McDermott, Britta Flach, Julie E. Ledgerwood, John R. Mascola, Barney S. Graham, Bob C. Lin, Sijy O’Dell, Stephen D. Schmidt, Alicia T. Widge, Venkata Viswanadh Edara, Evan J. Anderson, Lilin Lai, Katharine Floyd, Nadine Rouphael, Veronika I. Zarnitsyna, Paul C. Roberts, Mamodikoe Makhene, Wendy Buchanan, Catherine J. Luke, John H. Beigel, Lisa A. Jackson, Kathleen M. Neuzil, Hamilton Bennett, Brett Leav, Jim Albert, Pratap Kunwar - New England Journal of Medicine 2021 cited by 754

  9. Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trial

    Authors: Spyros Chalkias, Frank Eder, Brandon Essink, Shishir Khetan, Biliana Nestorova, Jing Feng, Xing Chen, Ying Chang, Honghong Zhou, David C. Montefiori, Darin K. Edwards, Bethany Girard, Rolando Pajón, Frank J. Dutko, Brett Leav, Stephen R. Walsh, Lindsey R. Baden, Jacqueline M. Miller, Rituparna Das - Nature Medicine 2022 cited by 144

  10. Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination

    Authors: Alicia T. Widge, Nadine Rouphael, Lisa A. Jackson, Evan J. Anderson, Paul C. Roberts, Mamodikoe Makhene, James D. Chappell, Mark R. Denison, Laura J. Stevens, Andrea J. Pruijssers, Adrian B. McDermott, Britta Flach, Bob C. Lin, Nicole A. Doria‐Rose, Sijy O’Dell, Stephen D. Schmidt, Kathleen M. Neuzil, Hamilton Bennett, Brett Leav, Mat Makowski, Jim Albert, Kaitlyn Cross, Venkata Viswanadh Edara, Katharine Floyd, Mehul S. Suthar, Wendy Buchanan, Catherine J. Luke, Julie E. Ledgerwood, John R. Mascola, Barney S. Graham, John H. Beigel - New England Journal of Medicine 2020 cited by 829

  11. Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial

    Authors: Laurence Chu, Keith Vrbicky, David C. Montefiori, Wenmei Huang, Biliana Nestorova, Ying Chang, Andrea Carfı́, Darin K. Edwards, Judy Oestreicher, Holly Legault, Frank J. Dutko, Bethany Girard, Rolando Pajón, Jacqueline M. Miller, Rituparna Das, Brett Leav, Roderick McPhee - Nature Medicine 2022 cited by 104

  12. A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine

    Authors: Laurence Chu, Roderick McPhee, Wenmei Huang, Hamilton Bennett, Rolando Pajón, Biliana Nestorova, Brett Leav - Vaccine 2021 cited by 237

  13. Treatment with Monoclonal Antibodies against Clostridium difficile Toxins

    Authors: Israel Lowy, Deborah C. Molrine, Brett Leav, Barbra M. Blair, Roger Baxter, Dale N. Gerding, Geoffrey Nichol, William D. Thomas, Mark D. Leney, Susan Sloan, Catherine A. Hay, Donna M. Ambrosino - New England Journal of Medicine 2010 cited by 745

  14. Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humans

    Authors: Jordan R. Willis, Madhu Prabhakaran, Michelle K. Muthui, Ansuya Naidoo, Troy Sincomb, Weiwei Wu, Christopher A. Cottrell, Elise Landais, Allan C. deCamp, Nahid Keshavarzi, Oleksandr Kalyuzhniy, Jeong Hyun Lee, Linda Murungi, Wilfrida A Ogonda, Nicole L. Yates, Martin Corcoran, Swastik Phulera, Joel Musando, Amanda Tsai, Gabrielle Lemire, Yiakon Sein, Michael Muteti, Praveen Alamuri, Jennifer A. Bohl, Drienna Holman, Sunny Himansu, Brett Leav, Caroline Reuter, Li‐An Lin, Baoyu Ding, Chunla He, Walter L. Straus, Kellie J. MacPhee, Isabel Regadas, Diana Nyabundi, Ruth Chirchir, Omu Anzala, John Kimotho, Caleb K. Kibet, Kelli Greene, Hongmei Gao, Erica L. Beatman, K Benson, Dominick J. Laddy, David M. Brown, Rhianna Bronson, Jalen Baptiste, Suprabhath Gajjala, Zahra Rikhtegaran Tehrani, Alison Benner, Mukundhan Ramaswami, Danny Lu, Nushin Alavi, Sonya Amirzehni, Michael Kubitz, Ryan Tingle, Erik Georgeson, Nicole Phelps, Yumiko Adachi, Alessia Liguori, Claudia Flynn, Katherine McKenney, Xiaoya Zhou, D. Collins Owuor, Sharon Owuor, S Kim, Michael Duff, Ju Yeong Kim, Grace Gibson, Sabyasachi Baboo, Jolene K. Diedrich, Torben Schiffner, Marisa Shields, Mabela Matsoso, Jairo Ivo dos Santos, Kristen Syvertsen, Allison Kennedy, Melissa Schroeter, Johan Vekemans, John R. Yates, James C. Paulson, Ollivier Hyrien, Adrian B. McDermott, Pholo Maenetje, Julien Nyombayire, Etienne Karita, Rosine Ingabire, Vinodh Edward, Vincent Muturi‐Kioi, Janine Maenza, Adrienne E. Shapiro, M. Juliana McElrath, Srilatha Edupuganti, Barbara S. Taylor, David Diemert, Gabriel Ozorowski, Richard A. Koup, David C. Montefiori, Andrew B. Ward, Gunilla B. Karlsson Hedestam and 8 more - Science 2025 cited by 60

  15. Immunogenicity of aIIV3, MF59-adjuvanted seasonal trivalent influenza vaccine, in older adults ≥65 years of age: Meta-analysis of cumulative clinical experience

    Authors: Uwe Nicolay, Esther Heijnen, Pantaleo Nacci, P. Patriarca, Brett Leav - International Journal of Infectious Diseases 2019 cited by 49

  16. Human Monoclonal Antibody HCV1 Effectively Prevents and Treats HCV Infection in Chimpanzees

    Authors: Trevor J. Morin, Teresa J. Broering, Brett Leav, Barbra M. Blair, Kirk J. Rowley, Elisabeth N. Boucher, Yang Wang, Peter Cheslock, Michael Knauber, David B. Olsen, S. Ludmerer, Gyöngyi Szabó, Robert W. Finberg, Robert H. Purcell, Robert E. Lanford, Donna M. Ambrosino, Deborah C. Molrine, Gregory J. Babcock - PLoS Pathogens 2012 cited by 166

  17. Initial analysis of viral dynamics and circulating viral variants during the mRNA-1273 Phase 3 COVE trial

    Authors: Rolando Pajón, Yamuna Devi Paila, Bethany Girard, Groves Dixon, Katherine Kacena, Lindsey R. Baden, Hana M. El Sahly, Brandon Essink, Kathleen M. Mullane, Ian Frank, Douglas Denhan, Edward Kerwin, Xiaoping Zhao, Baoyu Ding, Weiping Deng, Joanne E. Tomassini, Honghong Zhou, Brett Leav, F. Schödel - Nature Medicine 2022 cited by 36

  18. Retrospective Assessment of the Antigenic Similarity of Egg-Propagated and Cell Culture-Propagated Reference Influenza Viruses as Compared with Circulating Viruses across Influenza Seasons 2002–2003 to 2017–2018

    Authors: Sankarasubramanian Rajaram, Pirada Suphaphiphat, Josephine van Boxmeer, Mendel Haag, Brett Leav, Ike Iheanacho, Kristin Kistler, Raúl Ortíz de Lejarazu - International Journal of Environmental Research and Public Health 2020 cited by 32

  19. No immunological interference or concerns about safety when seasonal quadrivalent influenza vaccine is co-administered with a COVID-19 mRNA-1273 booster vaccine in adults: A randomized trial

    Authors: Abdi Naficy, Adrienne Kuxhausen, Harry Seifert, Andrew Hastie, Brett Leav, Jacqueline M. Miller, Kate Anteyi, Agnes Mwakingwe-Omari - Human Vaccines & Immunotherapeutics 2024 cited by 16

  20. Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI)

    Authors: Brett Leav, Barbra M. Blair, Mark D. Leney, Michael Knauber, Courtney Reilly, Israel Lowy, Dale N. Gerding, Ciarán P. Kelly, Kia Katchar, Roger Baxter, Donna M. Ambrosino, Deborah C. Molrine - Vaccine 2009 cited by 244

  21. Phase 3 Trial of mRNA-1273 during the Delta-Variant Surge

    Authors: Lindsey R. Baden, Hana M. El Sahly, Brandon Essink, Dean Follmann, Kathleen M. Neuzil, Allison August, Heather Clouting, Gabrielle Fortier, Weiping Deng, Shu Han, Xiaoping Zhao, Brett Leav, Carla Talarico, Bethany Girard, Yamuna Devi Paila, Joanne E. Tomassini, F. Schödel, Rolando Pajón, Honghong Zhou, Rituparna Das, Jacqueline M. Miller - New England Journal of Medicine 2021 cited by 63

  22. Prevention of influenza during mismatched seasons in older adults with an MF59-adjuvanted quadrivalent influenza vaccine: a randomised, controlled, multicentre, phase 3 efficacy study

    Authors: Jiřı́ Beran, Humberto Reynales, Airi Põder, Charles Yu, Punnee Pitisuttithum, Lee Li Yuan, Wim Vermeulen, Carole Verhoeven, Brett Leav, Bin Zhang, Daphne Sawlwin, Esther Hamers-Heijnen, Jonathan M. Edelman, Igor Smolenov - The Lancet Infectious Diseases 2021 cited by 48

  23. Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults

    Authors: Deborah Theodore, Angela R Branche, Lily Zhang, Daniel S. Graciaa, Madhu Choudhary, Timothy Hatlen, Raadhiya Osman, Tara M Babu, Samuel T. Robinson, Peter B. Gilbert, Dean Follmann, Holly Janes, James G. Kublin, Lindsey R. Baden, Paul Goepfert, Glenda Gray, Beatriz Grinsztejn, Karen L. Kotloff, Cynthia L. Gay, Brett Leav, Jacqueline M. Miller, Ian Hirsch, Jerald Sadoff, Lisa M. Dunkle, Kathleen M. Neuzil, Lawrence Corey, Ann R. Falsey, Hana M. El Sahly, Magdalena E. Sobieszczyk, Yunda Huang, COVID-19 Prevention Network (CoVPN), Atoya Adams, Eric N. Miller, Bruce G. Rankin, Steven Shinn, Marshall Nash, S Green, Colleen Jacobsen, Jayasree Krishnankutty, Sikhongi Phungwayo, Richard Glover, Stacy Slechta, Troy Holdeman, Robyn Hartvickson, Amber Grant, Terry L. Poling, Terry D. Klein, Thomas Klein, Tracy Klein, William Smith, Richard Gibson, Jennifer Winbigler, Elizabeth Parker, Priyantha N. Wijewardane, Eric Bravo, Jeffrey Thessing, Michelle Maxwell, Amanda Horn, Catherine Healy, Christine Akamine, Laurence Chu, R. Michelle Chouteau, Michael J. Cotugno, George H. Bauer, Greg Hachigian, Masaru Oshita, Michael Cancilla, Kristen Kiersey, William Seger, Mohammed Antwi, Allison Green, Anthony Kim, Michaël Desjardins, Jennifer Johnson, Amy C Sherman, Stephen R. Walsh, Judith Borger, Nafisa Saleem, Joel Solis, Martha Medina, Westly Keating, Edgar García, Cynthia Bueno, Nathan Segall, Douglas Denham, Thomas Weiss, Ayoade Avworo, Parke Hedges, Cynthia Strout, Rica Santiago, Yvonne Davis, Patty Howenstine, Alison Bondell, Kristin J. Marks, Tina Wang, Timothy Wilkin, Mary Vogler, Carrie D. Johnston, Michele P. Andrasik, Jessica Andriesen and 1,063 more - JAMA Network Open 2023 cited by 23

  24. Invasive Pulmonary Aspergillosis Associated with High-Dose Inhaled Fluticasone

    Authors: Brett Leav, Barry L. Fanburg, Susan Hadley - New England Journal of Medicine 2000 cited by 86